Qiaoling Song

Title: Qiaoling Song: Innovator in Anti-Tumor Drug Development

Introduction

Qiaoling Song is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor drugs. With a total of 2 patents, his work focuses on innovative approaches to cancer treatment.

Latest Patents

One of Qiaoling Song's latest patents is titled "Use of Tegaserod in Preparation of Anti-Tumor Drug." This patent discloses the use of Tegaserod or a pharmaceutically acceptable salt as a JAK-STAT3 signaling pathway inhibitor and an immunomodulator in the preparation of an anti-tumor drug. The findings indicate that Tegaserod exhibits excellent inhibitory effects on the growth of various tumor cells both in vivo and in vitro, showing promise for the treatment of various cancers. Another significant patent is "Application of Glucan in Preparation of Drug." This patent describes the use of a β-1,3/1,6-glucan in preparing a pharmaceutical composition that enhances the antitumor effects of immunotherapy, radiotherapy, or chemotherapy, and is intended for treating leukopenia and/or thrombocytopenia.

Career Highlights

Qiaoling Song has worked with reputable organizations, including the Marine Biomedical Research Institute of Qingdao and Qingdao Conson Pharmaceutical Co., Ltd. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Throughout his career, Qiaoling has collaborated with several professionals, including Jinbo Yang and Lijuan Wu, who have contributed to his research endeavors.

Conclusion

Qiaoling Song's innovative work in the field of anti-tumor drug development highlights his commitment to advancing cancer treatment. His patents reflect a significant contribution to pharmaceutical science, showcasing the potential for new therapies in oncology.